Evolus Total Liab from 2010 to 2025

EOLS Stock  USD 13.97  0.24  1.69%   
Evolus Total Liabilities yearly trend continues to be comparatively stable with very little volatility. Total Liabilities will likely drop to about 178.1 M in 2025. Total Liabilities is the total amount of all liabilities that Evolus Inc has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2015-12-31
Previous Quarter
214.5 M
Current Value
223.7 M
Quarterly Volatility
57.7 M
 
Yuan Drop
 
Covid
Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.1 M, Interest Expense of 16.7 M or Selling General Administrative of 190.1 M, as well as many indicators such as Price To Sales Ratio of 4.6, Dividend Yield of 0.0 or Days Sales Outstanding of 74.33. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.
  
Check out the analysis of Evolus Correlation against competitors.

Latest Evolus' Total Liab Growth Pattern

Below is the plot of the Total Liab of Evolus Inc over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Evolus' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Evolus Total Liab Regression Statistics

Arithmetic Mean138,914,291
Geometric Mean121,091,464
Coefficient Of Variation53.32
Mean Deviation65,432,416
Median159,484,000
Standard Deviation74,072,533
Sample Variance5486.7T
Range212.7M
R-Value0.77
Mean Square Error2417.4T
R-Squared0.59
Significance0.0005
Slope11,938,291
Total Sum of Squares82301.1T

Evolus Total Liab History

2025178.1 M
2024241.1 M
2023209.7 M
2022159.5 M
2021175.6 M
2020282 M
2019161 M

About Evolus Financial Statements

Evolus shareholders use historical fundamental indicators, such as Total Liab, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Liabilities241.1 M178.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.